Flagship Ventures Fund IV-RX, LP

Track

Insider profile

Flagship Ventures Fund IV-RX, LP's trades of Syros Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-13 2024-12-13
PrS Proposed sale
77,400
322.16
US$1,707,093 		77,400 322.16 US$1,707,093